AmCham Joins AMANATโs Republican Coordination Council on Entrepreneurship
3 Jan 2026, 14:38
AmCham Kazakhstan held a strategic consultation with Alexey Tsoy, ๐๐ฑ๐๐ถ๐๐ผ๐ฟ ๐๐ผ ๐๐ต๐ฒ ๐ฃ๐ฟ๐ฒ๐๐ถ๐ฑ๐ฒ๐ป๐ ๐ผ๐ณ ๐๐ต๐ฒ ๐ฅ๐ฒ๐ฝ๐๐ฏ๐น๐ถ๐ฐ ๐ผ๐ณ ๐๐ฎ๐๐ฎ๐ธ๐ต๐๐๐ฎ๐ป ๐ผ๐ป ๐ฆ๐ผ๐ฐ๐ถ๐ฎ๐น ๐๐๐๐๐ฒ๐, together with senior representatives of leading global pharmaceutical companies, including Pfizer, Johnson & Johnson, Bayer, Novo Nordisk, Takeda, Gedeon Richter Pharma GmbH, AbbVie, Boehringer Ingelheim, and AstraZeneca. The discussion was moderated by Madi Dautbek, PA Advisor at Aretera Public Affairs.
The meeting brought key stakeholders together on one platform to discuss priority issues for the development of the pharmaceutical sector:
๐น Improving access to medicines for the population
๐น Strengthening pharmaceutical supply and financing mechanisms
๐น Enhancing the effectiveness of SK-Pharmacy in ensuring uninterrupted supply
๐น Patent protection and data exclusivity
๐น Investment models and contract manufacturing opportunities
๐น Innovation, composite services, and ecosystem modernization
Participants agreed on the importance of maintaining regular dialogue and coordinated efforts to support a modern, efficient, and patient-centered pharmaceutical system in Kazakhstan.
AmCham Kazakhstan will continue to facilitate engagement between the public and private sectors to support sustainable industry development and the introduction of innovative solutions to the market.






